3月3日 - ** 药物开发商MAIA生物技术公司MAIA.A股价盘前大跌29%至1.47美元
** MAIA周一晚些时候宣布3000万美元公开发行股票的定价 (link)。
** 该公司以每股1.50美元的价格出售了2000万股股票，比股票最后收盘价折价27.5%。
** 此次发行由医疗保健领域的专业投资者与现有股东共同主导 - MAIA
** 募集资金将用于临床试验、运营资本和一般用途
** Konik Capital Partners 是此次发行的唯一簿记管理人
** 根据招股说明书，截至 3 月 2 日，MAIA 有 3,870 万股流通股 (link)
** 只有一位分析师将MAIA评为 "买入"，并给出了12.14美元的PT - 数据由LSEG汇编
** 截至上一交易日收盘，MAIA股价累计上涨35.3%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.